Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?
about
Coal dust exposure and mortality from ischemic heart disease among a cohort of U.S. coal minersHow to handle mortality when investigating length of hospital stay and time to clinical stabilityChemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer riskLifetime probabilities of hematopoietic stem cell transplantation in the U.SDesign of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis TrialBiomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosisSurvival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancerProspective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.Number needed to treat for time-to-event data with competing risks.Estimating twin concordance for bivariate competing risks twin data.Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data.Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system.A note on competing risks in survival data analysisIntroduction to the Analysis of Survival Data in the Presence of Competing RisksAnalysis of failure time hierarchical data in the presence of competing risks with application to oral contraceptive pill use in Egypt.Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.The risk of death associated with delayed coronary artery bypass surgeryCompeting risks analysis of correlated failure time data.Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosisCompeting risk regression models for epidemiologic data.Hospital mortality after hip fracture surgery in relation to length of stay by care delivery factors: A database study.Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.Practical methods for competing risks data: a review.Competing risk of death: an important consideration in studies of older adults.Prospective cohort study of fever incidence and risk in elderly persons living at home.A competing risks model for correlated data based on the subdistribution hazard.Competing risk models to estimate the excess mortality and the first recurrent-event hazardsNeonatal mortality of elk driven by climate, predator phenology and predator community composition.Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situOutcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up studyA Class of Semiparametric Mixture Cure Survival Models with Dependent Censoring.The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes.Mammographic density and breast cancer after ductal carcinoma in situ.Survival analysis in clinical trials: past developments and future directions.Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.Loss to follow-up as a competing risk in an observational study of HIV-1 incidence
P2860
Q23911985-AC023C39-839C-41FA-BE3C-9D8E400209FCQ23913313-91D4B819-BDA6-458D-BCB0-5A03E4B02E55Q24245375-364EFC97-CE60-45CE-91BB-6628B87ED98DQ24653888-5FD82F23-6E52-4DCB-808D-64B1D680D158Q28193653-0CF66DE5-D597-48BC-93DE-0BA180F14373Q28280822-212B8C03-6DED-4066-AC08-1FF66A8BED7CQ30251974-3C0BB99D-8225-4AB7-B86A-42FCE53F118BQ30371430-C443B8CF-ABF1-4BDD-B85C-34A20D5C49E2Q30423085-A29DCDC5-6C00-4CBD-8343-A1AB1D16CACAQ30666984-6C67E424-DD60-4DD7-AAA7-10866B59D872Q30678984-8C6E9D94-4966-4430-9A0F-060B07AD32E7Q30685539-4A9AD55C-3FE6-4B4F-81C1-C48E7254C5E1Q30845956-BF8EEFBD-A508-4CD2-BF00-CE24089512EEQ30951799-A9CC9FF9-35C7-473A-AE65-62D84C73CBD5Q31043722-AE635E92-BF2E-45D1-B328-C5D51526A7AEQ32048752-3162807B-8344-4706-A97A-AA28E79D2FDCQ32162246-69ED4265-38DE-435E-80DE-A0864F16D42FQ33248958-4B8011B9-630E-4A9F-9E3E-029F534D8666Q33293296-D3A90A7E-1247-4C19-8069-BDD217EDF963Q33416223-6D8BC87B-A3AE-45A2-8160-245B88BE162BQ33459711-0441991B-B934-4A67-AFF0-E83F40973A49Q33606253-767E4A7C-8943-4A01-ABB3-9ADC4FF9B8FAQ33627178-4EE1A496-8A4A-4D95-8636-465DC023841DQ33688929-41C92004-59D1-4441-8E93-C91063037112Q33724796-1B979E61-ECE9-4027-850D-7AC91857AF8CQ33788920-6A157D2E-48EA-4E56-A34E-4D8376004946Q33862367-32B624C3-601B-4189-839C-BB343F94DE42Q33879835-190C78BE-806B-4D95-A2E2-DC174B15841BQ33908677-AAA43F55-3600-4AAA-8AA2-09C7B98F5E58Q33911799-FE02DA08-76B3-4F24-8041-700F052F1BB1Q33912748-4DE2F3E1-BA5A-478A-A86D-0D457BD6CE96Q33924710-2D34B3E0-E0AE-4E2F-A5E3-A4EF6CEE8D13Q33965083-4F9F1F1B-5850-486A-921F-3D4FF7D4CF6CQ34060554-C0986D01-0BD6-494E-A029-D0F29DD9242FQ34072520-9C4F4531-E77A-4A1A-95E8-27C1D723FF45Q34110599-FB7FC655-C384-48B9-A502-6F8951355FCBQ34113236-DF820A2F-6A86-4454-8E67-BAA5B88DB5B9Q34449575-9CFF7735-AD24-4E95-9C90-7A5EB789EFB2Q34468742-7FB3799E-116C-40A8-8E25-5580195F47BFQ34649232-EAE770F6-2C39-499D-98D1-66F3B7019420
P2860
Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Kaplan-Meier, marginal or cond ...... eting risks failure time data?
@en
type
label
Kaplan-Meier, marginal or cond ...... eting risks failure time data?
@en
prefLabel
Kaplan-Meier, marginal or cond ...... eting risks failure time data?
@en
P356
P1476
Kaplan-Meier, marginal or cond ...... eting risks failure time data?
@en
P304
P356
10.1002/SIM.4780120803
P407
P577
1993-04-01T00:00:00Z